Market closed
Kintara Therapeutics Inc/$HURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kintara Therapeutics Inc
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
Ticker
$HURA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1
Website
HURA Metrics
BasicAdvanced
$144M
-
-$1.21
-
-
Price and volume
Market cap
$144M
52-week high
$4.00
52-week low
$1.80
Financial strength
Current ratio
3.679
Quick ratio
2.375
Long term debt to equity
0.293
Total debt to equity
1.388
Interest coverage (TTM)
-4.26%
Management effectiveness
Return on assets (TTM)
-90.68%
Return on equity (TTM)
-332.67%
Valuation
Price to book
2.89
Price to tangible book (TTM)
2.89
Price to free cash flow (TTM)
-3.053
Growth
Earnings per share change (TTM)
180.72%
HURA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kintara Therapeutics Inc stock?
Kintara Therapeutics Inc (HURA) has a market cap of $144M as of April 05, 2025.
What is the P/E ratio for Kintara Therapeutics Inc stock?
The price to earnings (P/E) ratio for Kintara Therapeutics Inc (HURA) stock is 0 as of April 05, 2025.
Does Kintara Therapeutics Inc stock pay dividends?
No, Kintara Therapeutics Inc (HURA) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Kintara Therapeutics Inc dividend payment date?
Kintara Therapeutics Inc (HURA) stock does not pay dividends to its shareholders.
What is the beta indicator for Kintara Therapeutics Inc?
Kintara Therapeutics Inc (HURA) does not currently have a Beta indicator.